Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

CureVac NV (CVAC)

NASDAQ
Currency in USD
Disclaimer
2.510
-0.090(-3.46%)
Closed
Pre Market
2.500-0.010(-0.40%)

CVAC Comments

You guys know this is a fraud right? Only propped up by insiders? No scientist believes this has any role to play...
is a dead story Curevac already expired.!-((( who invest in Curevac is a looser invest in VEON Amsterdam, very soon will jump to 1.80 euros per share .
it will pickup very soon 😉
down to below 50 level possible today
SELL thism trash!Nobody is going to take this vaccine when we have other grugs that 90-100* effacacy!They may get approval from EU and FDA but it will only be for third world nations
All vaccines are trash tho. XD
It will touch 65 today as lab results start showing promising......
Any concrete article/insert you can share to support?
The End . September bankruptcy .!
i am buying at dip....
They will announce bankruptcy soon!
i agree they decided and they will announce on September same story like Wirecard.
To all the (american?) Curevac bashers: Learn first about vaccine "business" testings before you write nonsense. The low effective percentage is a result of testing with many many Covid variantions (spread of variants). The high results of MRNA, BNTX, etc. are made with only one Covid variation. But hey... continue talking rubbish - until CVAC comes out with higher percentages for the most dangerous Covid variants.
dude when they come out Corona will be gone or other vaccin companys will serve the total market.. Curevac is too slow and has the worst product at the moment.... why should they get a 12 B + Mcap?
to the moon
12 B Mcap 120 Mio loss each Quater .. 0 Products and the new vaccin failed with 47 % eff. ... sure to the moon ...
it is as simple as that: Buy on bad news. Best from Berlin
Well, your opinion about german invetings you have very exclusively. Blind fish. Lets compare with the US: Germans have faster trains, the best Covid vaccine, better infrastructure, better healthcare system, better food quality, cleaner towns, more renewable energy better public transportation systems, etc. Oh yes, and americans buy much more german cars than Germans buy american. So... what did you say about investing?
Yesterday it open at 47, a magical opportunity and now the premarket is 67 and people don't want this stock. are you crazy !!! People talk about bankrut for curevac. You so funny!!!!
tomorrow?
the same story like Wirecard will bankrupt soon . Sell and take your damage back for ever. Curevac again one more scandal like Wirecard.! German stories.!-(((
Haha and the german says, Ex president Trump wanted to buy this ******** :D German liar to advertise yourself
lol, market cap 18bln$ with 17mln$ in revenue....
Exactly, I just wonder why it isn't zero yet
target for CVAC! After this drop I am thinking of gettin in...
Any chance it cud go bust like Wirecard
wow, you are brave
Guys , relax and look at this objectivelyit is very hard forecast. anyway i am ok about this situation, because i did not buy this stock
Man you´re my hero xD
I sold it a while back
Guys , relax and look at this objectivelyit is very hard forecast. anyway i am ok about this situation, because i did not buy this stock
Washington Post: CureVac, the latest experimental coronavirus vaccine, proved just 47 percent effective amid spread of variants, preliminary analysis shows
CureVac will bankrupt soon . forget it sell and run out . On September this CureVac will never exist . big institutions today already sold out in TradeGate .
still*
expiry date September 2021 . after you will loose your money sell out to save your capital.
Because the other vaccines have are higher effective only with a few older variants. They are not tested or went public with results of new dangerous variants. If Curevac would have testet with only 1 or 2 variants like the others have done before... the percentage would be much higher.
I will add more..nothing changes in the long term outlook
Serious question: why does nothing change? If they cannot get approval because it is not efficiant, they wont be able to sell their millions and millions of doses which they have already orders for. This cant be good LT. Management did not always take the right decisions in the last year which is not positive either…? How effective is their mrna staff and lab researchers? Hmmm. Having serious doubts here.
they need 50% to approve - it is 47% now and the trial still in progress. It's for countries which don't have enough vaccines anyway
Bad news - CureVac (CVAC/5CV GY) says its COVID-19 vaccine demonstrated an interim vaccine efficacy of 47% against COVID-19 disease of any severity and did not achieve prespecified statistical success criteria
buying time for new entrants..
oh really?
From the Motley Fool Germany. Just use Google Translate. https://www.onvista.de/news/curevac-aktie-trader-druecken-den-kurs-fuer-eine-interesssante-langfristige-einstiegschance-464032327
...
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.